2018
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. Journal Of The National Comprehensive Cancer Network 2018, 16: 693-702. PMID: 29891520, DOI: 10.6004/jnccn.2018.0056.Peer-Reviewed Original ResearchConceptsPrimary neuroendocrine tumorNeuroendocrine tumorsAdrenal tumorsManagement of NETsLocoregional advanced diseaseNCCN Guidelines InsightsAdrenal gland tumorsAdvanced diseaseNCCN guidelinesAdult patientsDistant metastasisGastrointestinal tractGland tumorsTumorsNeuroendocrineManagement optionsGuidelinesPatientsPheochromocytomaMetastasisParagangliomaDiseaseTract
2013
Diagnostic discrepancies between second-opinion and referring pathology reports of neuroendocrine tumors.
Lin H, Longacre T, Khandelwal V, Balise R, Kunz P. Diagnostic discrepancies between second-opinion and referring pathology reports of neuroendocrine tumors. Journal Of Clinical Oncology 2013, 31: e15011-e15011. DOI: 10.1200/jco.2013.31.15_suppl.e15011.Peer-Reviewed Original ResearchNeuroendocrine tumorsPathology reportsMitotic indexHistologic classification schemeStanford University HospitalMajority of casesHistological diagnosisUniversity HospitalAcademic hospitalTreatment planDiagnostic discrepanciesClinical diagnosisKi67Improved reportingNET casesHistological descriptionReporting guidelinesHospitalPathology expertsTumorsRelevant differencesDiagnosisReportFuture studiesGuidelinesConsensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, Chen H, Jensen RT, Kim MK, Klimstra DS, Kulke MH, Liu EH, Metz DC, Phan AT, Sippel RS, Strosberg JR, Yao JC. Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors. Pancreas 2013, 42: 557-577. PMID: 23591432, PMCID: PMC4304762, DOI: 10.1097/mpa.0b013e31828e34a4.Peer-Reviewed Original ResearchConceptsNeuroendocrine tumorsConsensus guidelinesNorth American Neuroendocrine Tumor SocietyPhase 3 trialTreatment of patientsHeterogeneous clinical presentationPractice-changing outcomesClinical presentationNovel agentsAnatomic locationTumorsHeterogeneous groupDegree of aggressivenessTreatmentDiseaseConsensus tableGuidelinesRigorous evaluationEverolimusSunitinibPatientsMalignancyPhysiciansTrials
2012
Neuroendocrine tumors.
Kulke MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, Clark OH, Doherty GM, Eason J, Emerson L, Engstrom PF, Goldner WS, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW, Moley JF, Pillarisetty VG, Saltz L, Schteingart DE, Shah MH, Shibata S, Strosberg JR, Vauthey JN, White R, Yao JC, Freedman-Cass DA, Dwyer MA. Neuroendocrine tumors. Journal Of The National Comprehensive Cancer Network 2012, 10: 724-64. PMID: 22679117, DOI: 10.6004/jnccn.2012.0075.Peer-Reviewed Original Research